A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
GATA2 deficiency is a rare disorder encompassing a broadly variable phenotype and its clinical picture is continuously evolving. Since it was first described in 2011, up to 500 patients have been reported. Here, we describe a cohort of 31 Italian patients (26 families) with molecular diagnosis of GATA2 deficiency. Patients were recruited contacting all the Italian Association of Pediatric Hematology and Oncology (AIEOP) centers, the Hematology Department in their institution and Italian societies involved in the field of vascular anomalies, otorhinolaryngology, dermatology, infectious and respiratory diseases. Median age at the time of first manifestation, molecular diagnosis and last follow-up visit was 12.5 (age-range, 2-52 years), 18 (age-range, 7-64 years) and 22 years (age-range, 3-64), respectively. Infections (39%), hematological malignancies (23%) and undefined cytopenia (16%) were the most frequent symptoms at the onset of the disease. The majority of patients (55%) underwent hematopoietic stem cell transplantation. During the follow-up rarer manifestations emerged. The clinical penetrance was highly variable, with the coexistence of severely affected pediatric patients and asymptomatic adults in the same pedigree. Two individuals remained asymptomatic at the last follow-up visit. Our study highlights new (pilonidal cyst/sacrococcygeal fistula, cholangiocarcinoma and gastric adenocarcinoma) phenotypes and show that lymphedema may be associated with null/regulatory mutations. Countrywide studies providing long prospective follow-up are essential to unveil the exact burden of rarer manifestations and the natural history in GATA2 deficiency.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Journal of clinical immunology - 43(2023), 8 vom: 30. Nov., Seite 2192-2207 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Roncareggi, Samuele [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
GATA2 Deficiency |
|---|
| Anmerkungen: |
Date Completed 15.12.2023 Date Revised 21.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10875-023-01583-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363305386 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363305386 | ||
| 003 | DE-627 | ||
| 005 | 20240222091412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10875-023-01583-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1301.xml |
| 035 | |a (DE-627)NLM363305386 | ||
| 035 | |a (NLM)37837580 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Roncareggi, Samuele |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.12.2023 | ||
| 500 | |a Date Revised 21.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a GATA2 deficiency is a rare disorder encompassing a broadly variable phenotype and its clinical picture is continuously evolving. Since it was first described in 2011, up to 500 patients have been reported. Here, we describe a cohort of 31 Italian patients (26 families) with molecular diagnosis of GATA2 deficiency. Patients were recruited contacting all the Italian Association of Pediatric Hematology and Oncology (AIEOP) centers, the Hematology Department in their institution and Italian societies involved in the field of vascular anomalies, otorhinolaryngology, dermatology, infectious and respiratory diseases. Median age at the time of first manifestation, molecular diagnosis and last follow-up visit was 12.5 (age-range, 2-52 years), 18 (age-range, 7-64 years) and 22 years (age-range, 3-64), respectively. Infections (39%), hematological malignancies (23%) and undefined cytopenia (16%) were the most frequent symptoms at the onset of the disease. The majority of patients (55%) underwent hematopoietic stem cell transplantation. During the follow-up rarer manifestations emerged. The clinical penetrance was highly variable, with the coexistence of severely affected pediatric patients and asymptomatic adults in the same pedigree. Two individuals remained asymptomatic at the last follow-up visit. Our study highlights new (pilonidal cyst/sacrococcygeal fistula, cholangiocarcinoma and gastric adenocarcinoma) phenotypes and show that lymphedema may be associated with null/regulatory mutations. Countrywide studies providing long prospective follow-up are essential to unveil the exact burden of rarer manifestations and the natural history in GATA2 deficiency | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a GATA2 Deficiency | |
| 650 | 4 | |a Hearing Loss, Sensorineural | |
| 650 | 4 | |a Lymphedema | |
| 650 | 4 | |a Myelodysplastic Syndrome | |
| 650 | 4 | |a Primary Immunodeficiency Diseases | |
| 700 | 1 | |a Girardi, Katia |e verfasserin |4 aut | |
| 700 | 1 | |a Fioredda, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Pedace, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Arcuri, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Badolato, Raffaele |e verfasserin |4 aut | |
| 700 | 1 | |a Bonanomi, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Borlenghi, Erika |e verfasserin |4 aut | |
| 700 | 1 | |a Cirillo, Emilia |e verfasserin |4 aut | |
| 700 | 1 | |a Coliva, Tiziana |e verfasserin |4 aut | |
| 700 | 1 | |a Consonni, Filippo |e verfasserin |4 aut | |
| 700 | 1 | |a Conti, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Farruggia, Piero |e verfasserin |4 aut | |
| 700 | 1 | |a Gambineri, Eleonora |e verfasserin |4 aut | |
| 700 | 1 | |a Guerra, Fabiola |e verfasserin |4 aut | |
| 700 | 1 | |a Locatelli, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Mancuso, Gaia |e verfasserin |4 aut | |
| 700 | 1 | |a Marzollo, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Masetti, Riccardo |e verfasserin |4 aut | |
| 700 | 1 | |a Micalizzi, Concetta |e verfasserin |4 aut | |
| 700 | 1 | |a Onofrillo, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Piccini, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Pignata, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Raddi, Marco Gabriele |e verfasserin |4 aut | |
| 700 | 1 | |a Santini, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Vendemini, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Biondi, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Saettini, Francesco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d 1981 |g 43(2023), 8 vom: 30. Nov., Seite 2192-2207 |w (DE-627)NLM012677426 |x 1573-2592 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2023 |g number:8 |g day:30 |g month:11 |g pages:2192-2207 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10875-023-01583-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2023 |e 8 |b 30 |c 11 |h 2192-2207 | ||